Tissue biology, from a blood draw
Aqtual’s functional liquid biopsy captures signals of gene activity from distant tissues in blood, helping clinicians and pharma understand disease biology, predict treatment response, and track how therapies change that biology over time.
One assay provides a functional view of disease biology with many applications.
The platform
Measure functional disease biology in blood. Identify which cell types and pathways are active, and track how treatment or disease progression trajectories change over time.
Learn morePersonalized testing
Aqtual is developing a pretreatment blood test to predict treatment response in patients with rheumatoid arthritis (RA), helping clinicians select the appropriate drug class. It is being evaluated in PRIMA-102, a prospective study of more than 1,400 patients.
Learn morePartnerships
Obtain non-invasive, repeatable, tissue-informed biological resolution from blood to inform treatment response and resistance mechanisms. Aqtual’s functional liquid biopsy and curated disease maps provide interpretable programs (cell states, pathways, tissue compartments, etc.) that delineate patient disease and treatment trajectories.
Learn morePublished in and Presented at Leading Scientific Journals and Conferences
All publicationsNature Communications Biology·npj Precision Oncology·Arthritis Care & Research·Annals of the Rheumatic Diseases·ASCO·EULAR·ACR Convergence·AACR
Our Investors Support Biotechnology Companies Tackling the World's Biggest Challenge
Contact Aqtual.
- media@aqtual.com
- 341-208-8569
- 31145 San Antonio St. Hayward, CA, 94544